{"transactions":[{"id":459530,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":16475,"kind":"organization","name":"KKR Biosimilar L.P.","position":1,"cik":"0001624314","reported_name":"KKR Biosimilar L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16476,"kind":"organization","name":"KKR Biosimilar GP LLC","position":2,"cik":"0001624305","reported_name":"KKR Biosimilar GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":335,"kind":"organization","name":"KKR Group Partnership L.P.","position":3,"cik":"0001472698","reported_name":"KKR Fund Holdings L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15904,"kind":"organization","name":"KKR Fund Holdings GP Ltd","position":4,"cik":"0001472697","reported_name":"KKR Fund Holdings GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16071,"kind":"organization","name":"KKR Group Holdings L.P.","position":5,"cik":"0001472696","reported_name":"KKR Group Holdings L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16072,"kind":"organization","name":"KKR Group Ltd","position":6,"cik":"0001472695","reported_name":"KKR Group Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":338,"kind":"organization","name":"KKR & Co. Inc.","symbol":"KKR","position":7,"cik":"0001404912","reported_name":"KKR & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":339,"kind":"organization","name":"KKR Management LLP","position":8,"cik":"0001472694","reported_name":"KKR Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":340,"kind":"person","name":"KRAVIS HENRY R","position":9,"cik":"0001081714","reported_name":"KRAVIS HENRY R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":341,"kind":"person","name":"ROBERTS GEORGE R","position":10,"cik":"0001081715","reported_name":"ROBERTS GEORGE R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2014-11-14T21:29:58.000Z","date":"2014-11-12","kind":"exercise","acquired":false,"shares":2499499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock is convertible into shares of common stock of Coherus BioSciences, Inc. (the \"Issuer\") on a one-for-one basis and automatically converted into shares of common stock of the Issuer on a one-for-one basis immediately prior to the completion of Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock is convertible into shares of common stock of Coherus BioSciences, Inc. (the \"Issuer\") on a one-for-one basis and automatically converted into shares of common stock of the Issuer on a one-for-one basis immediately prior to the completion of Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by KKR Biosimilar L.P. KKR Biosimilar GP LLC is the general partner of KKR Biosimilar L.P. KKR Fund Holdings L.P. is the sole member of KKR Biosimilar GP LLC. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P. KKR Group Holdings L.P. is the sole shareholder of KKR Fund Holdings GP Limited and a general partner of KKR Fund Holdings L.P. KKR Group Limited is the general partner of KKR Group Holdings L.P. KKR & Co. L.P. is the sole shareholder of KKR Group Limited. KKR Management LLC is the general partner of KKR & Co. L.P. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2499499},"source":{"system":"sec-edgar","filing":"0001104659-14-080993","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081715/000110465914080993/a4.xml","form_type":"4"}},{"id":459529,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":16475,"kind":"organization","name":"KKR Biosimilar L.P.","position":1,"cik":"0001624314","reported_name":"KKR Biosimilar L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16476,"kind":"organization","name":"KKR Biosimilar GP LLC","position":2,"cik":"0001624305","reported_name":"KKR Biosimilar GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":335,"kind":"organization","name":"KKR Group Partnership L.P.","position":3,"cik":"0001472698","reported_name":"KKR Fund Holdings L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15904,"kind":"organization","name":"KKR Fund Holdings GP Ltd","position":4,"cik":"0001472697","reported_name":"KKR Fund Holdings GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16071,"kind":"organization","name":"KKR Group Holdings L.P.","position":5,"cik":"0001472696","reported_name":"KKR Group Holdings L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16072,"kind":"organization","name":"KKR Group Ltd","position":6,"cik":"0001472695","reported_name":"KKR Group Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":338,"kind":"organization","name":"KKR & Co. Inc.","symbol":"KKR","position":7,"cik":"0001404912","reported_name":"KKR & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":339,"kind":"organization","name":"KKR Management LLP","position":8,"cik":"0001472694","reported_name":"KKR Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":340,"kind":"person","name":"KRAVIS HENRY R","position":9,"cik":"0001081714","reported_name":"KRAVIS HENRY R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":341,"kind":"person","name":"ROBERTS GEORGE R","position":10,"cik":"0001081715","reported_name":"ROBERTS GEORGE R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-14T21:29:58.000Z","date":"2014-11-12","kind":"exercise","acquired":true,"shares":2499499,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock is convertible into shares of common stock of Coherus BioSciences, Inc. (the \"Issuer\") on a one-for-one basis and automatically converted into shares of common stock of the Issuer on a one-for-one basis immediately prior to the completion of Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by KKR Biosimilar L.P. KKR Biosimilar GP LLC is the general partner of KKR Biosimilar L.P. KKR Fund Holdings L.P. is the sole member of KKR Biosimilar GP LLC. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P. KKR Group Holdings L.P. is the sole shareholder of KKR Fund Holdings GP Limited and a general partner of KKR Fund Holdings L.P. KKR Group Limited is the general partner of KKR Group Holdings L.P. KKR & Co. L.P. is the sole shareholder of KKR Group Limited. KKR Management LLC is the general partner of KKR & Co. L.P. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC."}],"balance_after":2499499,"source":{"system":"sec-edgar","filing":"0001104659-14-080993","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081715/000110465914080993/a4.xml","form_type":"4"}}]}